By Drug Target Review2025-06-17T08:30:19
Researchers at the University of Alabama have identified reelin, a glycoprotein known for its role in brain development, as a key regulator of neurons in the brain's reward centre, potentially making way for targeted therapies against cocaine use.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2026-03-27T13:06:00Z
2023-01-20T14:24:55
Sponsored by Leica Microsystems
2023-03-28T11:38:32
Sponsored by Bio-Techne
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2023-11-20T13:43:43
Sponsored by Merck
2024-01-09T09:30:19
Sponsored by Sartorius
Site powered by Webvision Cloud